IREM-1 is a novel inhibitory receptor expressed by myeloid cells - Wikidata - wikimedia - TriplyDB

IREM-1 is a novel inhibitory receptor expressed by myeloid cells

IREM-1 is a novel inhibitory receptor expressed by myeloid cells

http://www.wikidata.org/entity/Q28294075

about

CD300a and CD300f differentially regulate the MyD88 and TRIF-mediated TLR signalling pathways through activation of SHP-1 and/or SHP-2 in human monocytic cell lines CD84 negatively regulates IgE high-affinity receptor signaling in human mast cells Ancient divergence of a complex family of immune-type receptor genes.Expression, crystallization and X-ray data collection from microcrystals of the extracellular domain of the human inhibitory receptor expressed on myeloid cells IREM-1.Functional analysis of activating receptor LMIR4 as a counterpart of inhibitory receptor LMIR3.Sequence specificity of SHP-1 and SHP-2 Src homology 2 domains. Critical roles of residues beyond the pY+3 position.The CD300 molecules: an emerging family of regulators of the immune system.The Receptor CMRF35-Like Molecule-1 (CLM-1) Enhances the Production of LPS-Induced Pro-Inflammatory Mediators during Microglial Activation.CD300f immunoreceptor contributes to peripheral nerve regeneration by the modulation of macrophage inflammatory phenotype.The expression and function of human CD300 receptors on blood circulating mononuclear cells are distinct in neonates and adults Immune inhibitory receptors: essential regulators of phagocyte function.Antibody therapy for acute myeloid leukaemia.Regulation of neutrophil functions through inhibitory receptors: an emerging paradigm in health and disease.Interleukin-33 requires CMRF35-like molecule-1 expression for induction of myeloid cell activation.SHPS-1 and a synthetic peptide representing its ITIM inhibit the MyD88, but not TRIF, pathway of TLR signaling through activation of SHP and PI3K in THP-1 cells.Synthetic peptides containing ITIM-like domains block expression of inflammatory mediators and migration/invasion of cancer cells through activation of SHP-1 and PI3K.Synthetic peptides containing ITIM-like sequences of IREM-1 (CD300F) differentially regulate MyD88 and TRIF-mediated TLR signalling through activation of SHP and/or PI3K.Synthetic peptides containing ITIM-like sequences of IREM-1 inhibit BAFF-mediated regulation of interleukin-8 expression and phagocytosis through SHP-1 and/or PI3K.BAFF and APRIL induce inflammatory activation of THP-1 cells through interaction with their conventional receptors and activation of MAPK and NF-κB.Stimulation of FasL induces production of proinflammatory mediators through activation of mitogen-activated protein kinases and nuclear factor-κB in THP-1 cells.Characterization of leukocyte mono-immunoglobulin-like receptor 7 (LMIR7)/CLM-3 as an activating receptor: its similarities to and differences from LMIR4/CLM-5.Immune receptor expressed on myeloid cells 1 (IREM-1) inhibits B cell activation factor (BAFF)-mediated inflammatory regulation of THP-1 cells through modulation of the activities of extracellular regulated kinase (ERK).Human CD300C delivers an Fc receptor-γ-dependent activating signal in mast cells and monocytes and differs from CD300A in ligand recognition.CD300 heterocomplexes, a new and family-restricted mechanism for myeloid cell signaling regulation.Cloning and characterization of CD300d, a novel member of the human CD300 family of immune receptors.Negative regulation of autoimmune demyelination by the inhibitory receptor CLM-1.Effect of Specific Mutations in Cd300 Complexes Formation; Potential Implication of Cd300f in Multiple Sclerosis Overexpression of the immunoreceptor CD300f has a neuroprotective role in a model of acute brain injury.Monoclonal antibodies against IREM-1: potential for targeted therapy of AML.The CD300e molecule in mice is an immune-activating receptor.

P2860

Q28115250-364B20CD-4E7E-4587-89A1-1CE04AD021A8 Q28118474-E472A71F-74DF-4708-8B37-5F89FF36E882 Q31043059-484AF6B9-9AC3-45E3-A729-F994063B2F3B Q31103732-22479B36-C939-43DB-BD45-1725509AB9EB Q31109562-686E7A49-6D8A-463B-A1ED-C2E245646D60 Q33243531-AD9397F4-C257-47C3-A08F-37930D4EB71C Q34035020-DF5201E5-BDB3-402D-BF4A-574267A7B2F1 Q35618771-92F1B7FC-47A9-460F-A37B-B009078457F5 Q35936558-AC3C26E1-53B3-4D1D-A2BA-B85AAEDA5787 Q37232792-74A01BED-ABD9-448C-80B9-6537682C3C87 Q37839870-39FB53BD-725B-49E7-AF60-EB3477D0331D Q38169814-B298136A-3590-4487-B496-6D8645126160 Q38377860-A6D40366-454C-45DD-AF3C-15B993A7FF4E Q39209203-8DEE9480-5B0E-43BC-81C2-3CBBA1DB52F2 Q39211459-68372690-4262-4681-9954-63CD329911CA Q39351460-A002AAD8-5642-4D36-A521-DF52A7662E57 Q39404438-FEC660BF-8248-41D0-98B2-6EE27091DB07 Q39478976-3EA2A9B6-3CCA-4D4D-9B03-B58A194A5302 Q39555969-C3C3B0D2-77AC-4CBC-BF41-F24B9B44B9F7 Q39620643-89F90F31-28AD-42EA-B7BF-AC68A22A73AC Q39659418-FDEFB0B3-AAC7-4B86-AEB5-3D05CACC3DA9 Q39677902-5E284614-99E1-446B-ABB4-C07DFDD5C77D Q41116097-C61C8734-BA2D-4154-8DA1-765C89C67E8D Q41467332-0C21F395-8F2B-40FB-BF8F-240C72C20EE8 Q41828664-215C6E6D-BA68-4722-8C4C-91C80AEF186C Q41965864-54601D0A-72EA-452F-920F-0ED8BFC36729 Q42659862-EB1512FB-004F-44CA-A71F-9E054F388097 Q43725407-00705D33-FCA4-42DB-A623-B8BFD3290791 Q47805796-B5E5E501-B7D5-46ED-BD46-22E590074382 Q49874464-994A8051-8BE3-45AB-9AA5-A92FD17E0E29

P2860

IREM-1 is a novel inhibitory receptor expressed by myeloid cells

http://www.wikidata.org/entity/Q28294075

description

2004 nî lūn-bûn

@nan

2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

IREM-1 is a novel inhibitory receptor expressed by myeloid cells

@ast

IREM-1 is a novel inhibitory receptor expressed by myeloid cells

@en

IREM-1 is a novel inhibitory receptor expressed by myeloid cells

@nl

type

label

IREM-1 is a novel inhibitory receptor expressed by myeloid cells

@ast

IREM-1 is a novel inhibitory receptor expressed by myeloid cells

@en

IREM-1 is a novel inhibitory receptor expressed by myeloid cells

@nl

prefLabel

IREM-1 is a novel inhibitory receptor expressed by myeloid cells

@ast

IREM-1 is a novel inhibitory receptor expressed by myeloid cells

@en

IREM-1 is a novel inhibitory receptor expressed by myeloid cells

@nl

P1433

Q28294075-9AF0391F-55F0-4610-BC84-92C537FD6634

P1476

Q28294075-EE777C05-7EF2-4214-88E8-6A1D7A4EF2EF

P2093

Q28294075-9E4660C3-D481-4353-B507-814D5886A5CE

Q28294075-B9872CD7-8156-4805-8C52-AC2B60444D51

Q28294075-BDAE3D00-1C78-48EA-86A0-A6DBC7C44859

P2860

Q28294075-193E5630-395D-4DCD-944E-92EF630547E7

Q28294075-1F7BA5FD-22A1-4FC9-BC40-0570E083299E

Q28294075-3202D60A-184F-4032-86FF-0CDB7C35BA68

Q28294075-3D477A35-0575-4A43-BAA8-30F5765C72C2

Q28294075-41219BE2-5837-4C65-9F16-26E32FEF04DA

Q28294075-4212A1CD-70F7-44C4-B483-9367169BF4B9

Q28294075-51EC9CCE-8F75-4A87-9350-90954AA97888

Q28294075-56EDCC39-CB55-47AB-B1A6-91D74AEB2CC7

Q28294075-7A22B59B-3F99-4BE5-AEA0-1B34DF40D9B1

Q28294075-7AFA0734-F22D-4CF3-923D-BA07EE1D8A04

P304

Q28294075-A83EBC4E-F338-4469-89B2-6913BAE5CE6A

P31

Q28294075-752F4A94-2F33-4207-98BB-31A4D3EB1DA8

P3181

Q28294075-6251CB4E-7BF6-4DA3-AF1B-94561FB32106

P356

Q28294075-F302745E-93C8-4B31-B6E4-A948CD63E47D

P407

Q28294075-4AB221FC-9700-4EBD-BA7C-9568555586F8

P433

Q28294075-94EEA763-9277-42B8-BF82-BD9645012569

P478

Q28294075-35A2945C-3DC4-4B98-B091-9CB8613A0C98

P50

Q28294075-8A2656D2-5F84-4865-857B-588046E28F19

Q28294075-F05223B1-5837-40DD-BE6C-F9D5EF71B545

Q28294075-FDE58847-2DFF-4C52-9D62-FF2D3CC384DB

P577

Q28294075-71ACE714-C60A-4ECD-B768-8C1EA7E935B6

P5875

Q28294075-2606A4D5-C2B3-4FB5-9D80-1037BDB21408

P698

Q28294075-4D5A753A-D94B-4119-8369-A287650F9C0C

P3181

P356

P1433

European Journal of Immunology

P1476

IREM-1 is a novel inhibitory receptor expressed by myeloid cells

@en

P2093

Friederike Kitzig

http://www.w3.org/2001/XMLSchema#string

Helena Aguilar

http://www.w3.org/2001/XMLSchema#string

Tamara Brckalo

http://www.w3.org/2001/XMLSchema#string

P2860

The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM

Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells

PILRalpha, a novel immunoreceptor tyrosine-based inhibitory motif-bearing protein, recruits SHP-1 upon tyrosine phosphorylation and is paired with the truncated counterpart PILRbeta

Cell surface receptors Ly-9 and CD84 recruit the X-linked lymphoproliferative disease gene product SAP

Differential functions of the two Src homology 2 domains in protein tyrosine phosphatase SH-PTP1

A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing

NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses

The CMRF-35H gene structure predicts for an independently expressed member of an ITIM/ITAM pair of molecules localized to human chromosome 17

Transcriptional regulation by calcium, calcineurin, and NFAT

Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A.

P304

3690-3701

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3672280

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/EJI.200425433

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P50

Miguel López-Botet

Damiana Alvarez Errico

P577

2004-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8177041

http://www.w3.org/2001/XMLSchema#string

P698

15549731

http://www.w3.org/2001/XMLSchema#string